BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25209964)

  • 1. Epidemiology of de novo malignancies after solid-organ transplantation: immunosuppression, infection and other risk factors.
    Piselli P; Verdirosi D; Cimaglia C; Busnach G; Fratino L; Ettorre GM; De Paoli P; Citterio F; Serraino D
    Best Pract Res Clin Obstet Gynaecol; 2014 Nov; 28(8):1251-65. PubMed ID: 25209964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo malignancies after organ transplantation: focus on viral infections.
    Piselli P; Busnach G; Fratino L; Citterio F; Ettorre GM; De Paoli P; Serraino D;
    Curr Mol Med; 2013 Aug; 13(7):1217-27. PubMed ID: 23278452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early de novo malignancies after kidney transplantation.
    Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
    Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
    Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
    Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence after immunosuppressive treatment following kidney transplantation.
    Andrés A
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancies in organ transplant recipients.
    Hoshida Y; Aozasa K
    Pathol Int; 2004 Sep; 54(9):649-58. PubMed ID: 15363032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National survey of de novo malignancy after solid organ transplantation in Japan.
    Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
    Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatopathology of skin cancer in solid organ transplant recipients.
    Stoff B; Salisbury C; Parker D; O'Reilly Zwald F
    Transplant Rev (Orlando); 2010 Oct; 24(4):172-89. PubMed ID: 20709518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
    Gutierrez-Dalmau A; Campistol JM
    Drugs; 2007; 67(8):1167-98. PubMed ID: 17521218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.
    Katabathina VS; Menias CO; Tammisetti VS; Lubner MG; Kielar A; Shaaban A; Mansour J; Surabhi VR; Hara AK
    Radiographics; 2016; 36(5):1390-407. PubMed ID: 27618321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy after solid organ transplantation: an overview.
    Zafar SY; Howell DN; Gockerman JP
    Oncologist; 2008 Jul; 13(7):769-78. PubMed ID: 18614590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer after kidney transplantation].
    Sandrini S; Setti G; Bossini N; Maiorca P
    G Ital Nefrol; 2004; 21 Suppl 26():S67-73. PubMed ID: 15732048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
    Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early de novo neoplasia after renal transplantation].
    Veroux P; Veroux M; Puliatti C; Amodeo C; Macarone M; Cappello D; Caglià P
    Tumori; 2003; 89(4 Suppl):301-4. PubMed ID: 12903627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Skin cancer in renal transplant recipients].
    Mangino M; Schena FP
    G Ital Nefrol; 2010; 27 Suppl 50():S75-80. PubMed ID: 20922700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Presentation of cancers in recipients of a solid-organ transplant].
    Lampreabe I; Gómez-Ullate P; Amenábar JJ; Zárraga S; Gaínza FJ; Urbizu JM
    Nefrologia; 2001; 21(6):528-37. PubMed ID: 11881422
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncologic issues and kidney transplantation: a review of frequency, mortality, and screening.
    Asch WS; Bia MJ
    Adv Chronic Kidney Dis; 2014 Jan; 21(1):106-13. PubMed ID: 24359993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.